Has Amy Chodorowski received payments from drug or device companies?

Yes. Drug and device makers reported $3,676 in general payments to Amy Chodorowski across 129 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amy Chodorowski did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amy Chodorowski come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amy Chodorowski

Psychiatric/Mental Health · Chicago, ILNPI 1821688417

Payments from drug & device makers

$3,676in general payments, 2019–2025

Across 129 payments — averaging $28.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka America Pharmaceutical, Inc.$564
Johnson & Johnson$519
AbbVie$494
Neurocrine Biosciences, Inc.$423
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$366
Alkermes, Inc.$274
plus $1K from 15 others

What the payments were for

Food & beverage$3,676100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	21	$564
Johnson & Johnson	11	$519
AbbVie	24	$494
Neurocrine Biosciences, Inc.	8	$423
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	13	$366
Alkermes, Inc.	6	$274
Axsome Therapeutics, Inc.	6	$165
Tris Pharma Inc	5	$155
Idorsia Pharmaceuticals US Inc	1	$122
Corium, LLC	9	$111
Teva Pharmaceuticals USA, Inc.	5	$105
Lundbeck LLC	4	$76
Supernus Pharmaceuticals, Inc.	4	$72
E.r. Squibb & Sons, L.L.C.	3	$61
Ironshore Pharmaceuticals Inc.	2	$41
Noven Therapeutics, LLC	2	$35
Neos Therapeutics, LP	1	$23
Vanda Pharmaceuticals Inc.	1	$21
Collegium Pharmaceutical, Inc.	1	$20
Takeda Pharmaceuticals U.S.A., Inc.	1	$16
Biogen	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,676 in reported general payments places this provider in the 85th percentile of 922 psychiatric/mental health providers in Illinois.

See all psychiatric/mental health providers in Illinois →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluoxetine Hcl	14	$1,320
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	25	$713
Lamotrigine	13	$127
Hydroxyzine Pamoate	13	$66
Sertraline Hcl	13	$61

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Chicago

Erin PetrusicChicago$517K
Maurice BrownleeChicago$162K
Melissa VitaleChicago$151K
Alan AmbergChicago$119K
Julie CarbrayChicago$36K
Abigail HamiltonChicago$14K
Anh NguyenChicago$9K
Sherann IvyChicago$8K
Annabella Vidal-RuizChicago$8K
Dina Pierre-GrayChicago$7K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →